Whalesbook
Geojit Financial Services has issued a 'SUBSCRIBE' rating for the upcoming Initial Public Offering (IPO) of Sudeep Pharma Ltd. The company, a technology-led manufacturer of pharmaceutical excipients and specialty food/nutrition ingredients, operates globally with three facilities in Gujarat and one in Ireland. Geojit highlights strong growth projections for both the excipient market (expected to reach USD 13 billion by 2029) and specialty food ingredients (expected to reach USD 118 billion by 2029), making this IPO attractive for medium- to long-term investors.